GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (XTER:IX1) » Definitions » Cyclically Adjusted Revenue per Share

IDEXX Laboratories (XTER:IX1) Cyclically Adjusted Revenue per Share : €30.94 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is IDEXX Laboratories Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

IDEXX Laboratories's adjusted revenue per share for the three months ended in Mar. 2024 was €10.565. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €30.94 for the trailing ten years ended in Mar. 2024.

During the past 12 months, IDEXX Laboratories's average Cyclically Adjusted Revenue Growth Rate was 12.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 16.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 15.40% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 13.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of IDEXX Laboratories was 16.30% per year. The lowest was 12.20% per year. And the median was 13.90% per year.

As of today (2024-05-23), IDEXX Laboratories's current stock price is €479.90. IDEXX Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €30.94. IDEXX Laboratories's Cyclically Adjusted PS Ratio of today is 15.51.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of IDEXX Laboratories was 30.79. The lowest was 5.06. And the median was 13.35.


IDEXX Laboratories Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for IDEXX Laboratories's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories Cyclically Adjusted Revenue per Share Chart

IDEXX Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 21.49 26.57 29.11

IDEXX Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.41 27.99 30.02 29.11 30.94

Competitive Comparison of IDEXX Laboratories's Cyclically Adjusted Revenue per Share

For the Diagnostics & Research subindustry, IDEXX Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDEXX Laboratories's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where IDEXX Laboratories's Cyclically Adjusted PS Ratio falls into.



IDEXX Laboratories Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, IDEXX Laboratories's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=10.565/131.7762*131.7762
=10.565

Current CPI (Mar. 2024) = 131.7762.

IDEXX Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 2.772 100.560 3.633
201409 2.953 100.428 3.875
201412 2.946 99.070 3.919
201503 3.700 99.621 4.894
201506 3.905 100.684 5.111
201509 3.898 100.392 5.117
201512 3.996 99.792 5.277
201603 4.128 100.470 5.414
201606 4.572 101.688 5.925
201609 4.383 101.861 5.670
201612 4.632 101.863 5.992
201703 4.800 102.862 6.149
201706 5.040 103.349 6.426
201709 4.625 104.136 5.853
201712 4.802 104.011 6.084
201803 4.902 105.290 6.135
201806 5.611 106.317 6.955
201809 5.285 106.507 6.539
201812 5.499 105.998 6.836
201903 5.823 107.251 7.155
201906 6.264 108.070 7.638
201909 6.269 108.329 7.626
201912 6.244 108.420 7.589
202003 6.538 108.902 7.911
202006 6.553 108.767 7.939
202009 7.069 109.815 8.483
202012 6.813 109.897 8.169
202103 7.516 111.754 8.863
202106 7.913 114.631 9.097
202109 7.963 115.734 9.067
202112 8.229 117.630 9.219
202203 8.877 121.301 9.644
202206 9.593 125.017 10.112
202209 10.106 125.227 10.635
202212 9.331 125.222 9.819
202303 10.014 127.348 10.362
202306 10.371 128.729 10.617
202309 10.213 129.860 10.364
202312 9.849 129.419 10.028
202403 10.565 131.776 10.565

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


IDEXX Laboratories  (XTER:IX1) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

IDEXX Laboratories's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=479.90/30.94
=15.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of IDEXX Laboratories was 30.79. The lowest was 5.06. And the median was 13.35.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


IDEXX Laboratories Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


IDEXX Laboratories (XTER:IX1) Business Description

Address
One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.

IDEXX Laboratories (XTER:IX1) Headlines

No Headlines